Peer-reviewedCC BYFrontiers in medicine
A trial of exosome rich stem cell secretome as a potential treatment for Hypermobile Ehlers-Danlos Syndrome
- 1Independent Researcher , , ,
- 2Direct Biologics , Medical Affairs, , ,
- 3McGrath Medical , , ,
Related
- Potential role of resveratrol in abdominal cocoon syndrome: targeting inflammation, oxidative stress, and fibrosis via food-derived bioactive compounds resveratrol for treatment of abdominal cocoon syndrome
- Clinical characteristics of postural tachycardia syndrome with and without hypermobile Ehlers-Danlos syndrome: a pilot study
- Unraveling Gastrointestinal Symptoms in Hypermobile Ehlers–Danlos Syndrome: A Functional and Structural Diagnostic Perspective
- Stem cell secretome-enriched hydrogels as a potential therapeutic approach for osteoarthritis
- More common than we thought: Hypermobile Ehlers-Danlos Syndrome, comorbidity burden, and long COVID risk in a national cohort
BibTeX
@article{flynn2026trial,
title = {{A trial of exosome rich stem cell secretome as a potential treatment for Hypermobile Ehlers-Danlos Syndrome}},
author = {Kevin J. Flynn and John T. Ransom and Daniel McGrath},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13657981},
note = {CC BY},
}
RIS
TY - JOUR
TI - A trial of exosome rich stem cell secretome as a potential treatment for Hypermobile Ehlers-Danlos Syndrome
AU - Kevin J. Flynn
AU - John T. Ransom
AU - Daniel McGrath
PY - 2026
DA - 2026/10/16
JO - Frontiers in medicine
UR - https://europepmc.org/article/PMC/PMC13657981
SN - 2296-858X
ER -